Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
HEMOLENS DIAGNOSTICS logo — to keep you going

HEMOLENS DIAGNOSTICS

to keep you going

Founded 2015 Poland Poland 83 employees

General Information

Company Name HEMOLENS DIAGNOSTICS
Founded Year 2015
Location Poland Poland +1
Employees 83
Social

Get notified when HEMOLENS DIAGNOSTICS moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About HEMOLENS DIAGNOSTICS

HMoleNS Diagnostics aims to revolutionize cardiac diagnostics and make a significant impact on global healthcare. By addressing the shortcomings of current diagnostic pathways, the company offers a promising solution to the widespread issue of inaccurate diagnosis and unnecessary invasive procedures in identifying atherosclerosis. Founded in 2015 and based in Poland, the team comprising bioengineers, cardiologists, and ICT professionals has developed an innovative, non-invasive method to detect coronary artery disease. With the potential to save lives and reduce healthcare costs, HMoleNS Diagnostics is poised to attract substantial interest from investors seeking to support groundbreaking solutions in the medical industry. The company's dedication to advancing cardiac care aligns with the growing demand for innovative technologies in the healthcare sector, making it a compelling opportunity for venture capital investment.

Taxonomy: Cardiac Diagnostics, Atherosclerosis Detection, Non-Invasive Technology, Healthcare Innovation, Bioengineering, Cardiology Expertise, ICT Integration, Medical Technology, Innovative Diagnostics, Coronary Artery Disease, Patient Care Improvement

No funding data available for HEMOLENS DIAGNOSTICS yet.

Get notified when HEMOLENS DIAGNOSTICS raises funding

HEMOLENS DIAGNOSTICS Alternatives & Competitors

HEMOLENS DIAGNOSTICS vs
HeartMetrics
HeartMetrics United States

Automated, non-invasive algorithms swiftly measure coronary blood flow from standard heart CTA image...

Grant
2 employees
Health Care, Medical Devices
HEMOLENS DIAGNOSTICS vs
Life Flow
Life Flow

Leading the way in non-invasive cardiac diagnostics with advanced Computational Fluid Dynamics techn...

Seed
51-200 employees
Health Care, Life Sciences
HEMOLENS DIAGNOSTICS vs
Fibronostics
Fibronostics United States

An In vitro diagnostics platform for metabolic conditions detection and prognosis, powered by artifi...

23 employees
Health Care

FAQ About HEMOLENS DIAGNOSTICS

to keep you going
HEMOLENS DIAGNOSTICS was founded in 2015.
HEMOLENS DIAGNOSTICS is headquartered in Poland.
HEMOLENS DIAGNOSTICS has approximately 83 employees.
Top alternatives and competitors to HEMOLENS DIAGNOSTICS include HeartMetrics, Life Flow, Fibronostics, Heartflow, Cleerly. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
HEMOLENS DIAGNOSTICS and HeartMetrics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors HEMOLENS DIAGNOSTICS and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy